Management of Portal Hypertension: From Considerations in MASLD and the Assessment of Frailty

Nov 10 2025
Convention Center: Room 202, Level 2
2:00 PM - 3:30 PM

World Class Speakers

Jasmohan S. Bajaj, MD, FAASLD
Abstract Presenter

Jasmohan S. Bajaj, MD, FAASLD

Virginia Commonwealth University
Raj Vuppalanchi, MD, FAASLD
Abstract Presenter

Raj Vuppalanchi, MD, FAASLD
Heather Patton, MD, FAASLD
Moderator

Heather Patton, MD, FAASLD

VA San Diego Healthcare
Nikhilesh Mazumder, MD, MPH
Moderator

Nikhilesh Mazumder, MD, MPH

University of Michigan Hospitals and Health Centers

Description

Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Journey Maps

Presentations

2:30 PM - 2:45 PM
Jun 25 2026
Convention Center - Room 202, Level 2

Frailty, Cognitive Impairment and Comorbid Conditions add to Cirrhosis Severity in Prediction of 12-month Hospitalizations in a Multi-center Outpatient Cirrhosis Cohort

Jasmohan S. Bajaj, MD, FAASLD , Abstract Presenter
Cirrhosis and Portal Hypertension
3:00 PM - 3:15 PM
Jun 25 2026
Convention Center - Room 202, Level 2

Belapectin Reduces Liver Stiffness Progression and Prevents Varices at 18 Months in MASH Cirrhosis: Results from the NAVIGATE Trial

Raj Vuppalanchi, MD, FAASLD , Abstract Presenter
Cirrhosis and Portal Hypertension

Objectives

  • Summarize the importance of frailty assessment in patients with cirrhosis